Prixa Raises US$ 3 Million Funding to Improve Healthcare

Prixa, recently secured additional US$3 million of funding, led by MDI and TPTF with participation from existing investors, including the Siloam Hospitals Group.

It will be used to expand the reach of lplatform and user base, support the company B2B customer base, and increase accessibility to healthcare and the digital transformation of Indonesia’s healthcare services.

Prixa was founded in 2019 and is led by James Roring, MD. This startup was first launched with an Artificial Intelligence based health management platform.

This platform provides telemedicine and other basic primary care services to healthcare payers with the mission of humanizing healthcare by leveraging data and technology.

During the pandemic conditions in Indonesia, Prixa is experiencing exponential growth for its services, including online medical consultations or telemedicine.

This platform allows users to connect directly with primary care services, which include telemedicine consultation, drug delivery, and on-demand laboratory tests.

Barry Lee, Managing Director of the Trans-Pacific Technology Fund said, “As an international venture fund, we see a significant opportunity to support the healthcare industry in Indonesia through cutting-edge technology.

“We look forward to contributing the global experience in this sector that we gain from our portfolio of other health technology companies to support Prixa’s growth,” he said.

Supporting the Digitization of Public Health Services

Prixa focuses on healthcare payer services, which include insurance companies, corporations, and government entities; currently serving about 10 million users.

With the aim of reducing claims and healthcare costs, Prixa strives to provide healthcare in a paradigmatic way through a managed care approach.

It’s also in line with the company’s support for government programs for digital transformation in the healthcare sector and for improving health services across all levels of society.

Prixa has a proven track record of increasing patient satisfaction by providing telemedicine services that are fast and easy to use.

“The cost of insurance claims can be more efficient with the effective use of telemedicine in primary care, and allows hospitals to continue to improve the quality of digital patient care during the pandemic,” said Aditia Henri Narendra, GM Legal and Corporate Communications at MDI Ventures.

James Roring, the CEO and Co-founder of Prixa added, “There is a dichotomy in healthcare where there is constant innovation in advanced patient care but access to basic healthcare services continues to lag behind.

“Prixa was built to facilitate access to health services through technology, which we use to reduce health care costs,” he said.

Budi Setyawan, Chief Strategy Officer of P. Telekomunikasi Indonesia, Tbk also said that MDI’s consistency in investing in startups shows Telkom’s commitment to strengthening Indonesia’s digital business landscape.

Previously, Alodokter also Received Funding Several Ventures

Alodokter announced that the company received another injection of funds from MDI Ventures, a subsidiary of the Telkom group and Samsung Ventures for an undisclosed amount.

Alodokter itself has managed to raise significant funding since 2019, from investors such as Softbank Ventures, Sequis, Golden Gate Ventures, Philips, Heritas, and Hera Capital.

With the fresh funds, Alodokter will use it to expand and digitize the healthcare ecosystem and develop new products on its platform.

The platform is currently connected to more than 43 thousands of doctors and 1,500 hospitals and clinics with millions of patients in Indonesia.

Through its platform, Alodokter provides comprehensive digital health services that include health content, access to general practitioners and specialists, online ordering for doctor’s appointments at hospitals, purchasing drugs through e-pharmacy, and insurance packages.

CEO and Founder of Alodokter Nathanael Faibis revealed that new financing from MDI Ventures and Samsung Ventures will be directed to continue to improve the Alodokter healthcare ecosystem.